Imaging is now becoming an increasing important tool in both clinical and research. A wide range of imaging techniques commercially available provides sensitivity to visualization of brain structure and function from the level of individual molecules to whole brain. Hence, brain imaging helps the researchers or the physicians to identify the area of brain which are affected by neurological disorders.
A new research report by Transparency Market Research features the changing trends and future growth prospects of the global brain imaging, biomarkers and neuroinformatics market. As per the report, imaging has now become an essential tool for research and clinical activities. Brain imaging assists physicians and researchers to find areas of the brain that are affected by neurological disorders. Brain imaging is also being increasingly used to formulate new strategies to treat various brain disorders. Non-invasive brain imaging techniques help physicians and researchers to find out neural networks in the cognitive pathway.
The report, titled “Brain Imaging, Biomarkers and NeuroInformatics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” defines brain imaging, biomarkers, and neuroinformatics. Biomarkers identify the progress of a disease and evaluate the most effective therapy for the disease. Neuroinformatics consists software systems and multidimensional databases that store, analyze, and manage information from genetic to behavioral level. Biomarkers play a key role in neuroscience to identify the number of abnormalities and neurological disorders.
Get PDF Brochure for more Professional and Technical industry insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3851
The rising number of aging people is the root cause of the rising number of neurological disorders. Thus, this is also expected to propel the global brain imaging, biomarkers and neuroinformatics market throughout the forecast period. Aged people are prone to various neurological disorders, brain disorders, and cardiovascular diseases. According to the World Health Organization, approximately 14.1% of the global population are likely to suffer from various neurological disorders by 2020. This is expected to create growth opportunities for key players operating in the global brain imaging, biomarkers and neuroinformatics market.
Some of the companies operating in the global brain imaging, biomarkers and neuroinformatics market are Abbot Diagnostics, Advanced Brain Monitoring, Johnson & Johnson, NeuroVigil, Philips Healthcare, Aspect Medical (Covidien), Natus Medical, Zynex, Brain Resource, Electrical Geodesics, GE Healthcare, Bio-Rad, Quest Diagnostics, NeuroVista, and BrainScope. Many players are concentrating on upgrading neuroimaging techniques such as computed tomography, nuclear medicine imaging, magnetoencephalography (EEG), and electroencephalography.
The global brain imaging, biomarkers and neuroinformatics market is regionally divided into Asia Pacific, North America, Europe, and Rest of the World. At present, the global brain imaging, biomarkers and neuroinformatics market is dominated by North America, followed by Europe. However, Asia Pacific is predicted to be the most promising market for brain imaging, biomarkers and neuroinformatics in the coming future. It is found that, globally every year, around 100 million people suffer from nervous system or brain disorders such as Parkinson’s disease, Alzheimer’s disease, schizophrenia, and sleep disorders. This is predicted to propel the demand for brain imaging, biomarkers and neuroinformatics.